Compare Amgen, Inc. (AMGN) vs Southern Copper Corp (SCCO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs Southern Copper Corp — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while Southern Copper Corp trades at $174.85 (market cap $146.70B). The key difference: Amgen, Inc. is the larger of the two by market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | SCCO | |
|---|---|---|
Market Cap | $196.12B | $146.70B |
Sector | Health | Basic Materials |
52-Week High | $388.16 | $218.85 |
52-Week Low | $271.18 | $90.54 |
Enterprise Value | $241.41B | $148.75B |
Dividend Yield | 2.77% | 2.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
SCCO trades at $175.83, up 0.8% on the day, with a neutral technical signal and bearish moving averages. The stock exhibits strong fundamentals, with revenue growing from $10.0B in 2022 to $13.4B in 2025 and net income margin expanding to 34.13%. Recent earnings beats and a $1.00 dividend payment in May 2026 highlight operational strength. However, valuation ratios like a P/E of 29.77 and P/B of 12.45 suggest premium pricing relative to historical norms.
The outlook for SCCO is mixed; robust earnings growth and positive analyst coverage from Zacks (Strong Buy on July 10, 2026) support upside potential, but high valuations and a consensus price target of $151.58 indicate near-term overvaluation risks. Key risks include commodity price volatility and execution challenges in capital expenditures, while institutional sentiment remains cautious with only 10.34% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
